3 Health Services Stocks Moving The Industry Upward

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

One out of the three major indices are trading lower today with the Dow Jones Industrial Average ( ^DJI) trading down 29 points (-0.2%) at 16,367 as of Wednesday, March 5, 2014, 11:55 AM ET. The NYSE advances/declines ratio sits at 1,229 issues advancing vs. 1,681 declining with 174 unchanged.

The Health Services industry currently sits down 0.1% versus the S&P 500, which is unchanged. Top gainers within the industry include Select Medical Holdings Corporation ( SEM), up 4.3%, Globus Medical ( GMED), up 4.0% and DexCom ( DXCM), up 2.5%. On the negative front, top decliners within the industry include Mindray Medical International Limited ADR r ( MR), down 1.8%, Fresenius Medical Care AG & Co. KGaA ( FMS), down 1.3%, CareFusion ( CFN), down 1.1%, Becton Dickinson ( BDX), down 0.9% and HCA Holdings ( HCA), down 0.9%.

TheStreet would like to highlight 3 stocks pushing the industry higher today:

3. Aetna ( AET) is one of the companies pushing the Health Services industry higher today. As of noon trading, Aetna is up $0.48 (0.7%) to $74.13 on light volume. Thus far, 878,014 shares of Aetna exchanged hands as compared to its average daily volume of 2.6 million shares. The stock has ranged in price between $73.11-$74.22 after having opened the day at $73.52 as compared to the previous trading day's close of $73.65.

Aetna Inc. operates as a diversified health care benefits company in the United States. The company operates in three segments: Health Care, Group Insurance, and Large Case Pensions. Aetna has a market cap of $26.2 billion and is part of the health care sector. Shares are up 5.3% year-to-date as of the close of trading on Tuesday. Currently there are 12 analysts who rate Aetna a buy, no analysts rate it a sell, and 5 rate it a hold.

TheStreet Ratings rates Aetna as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, growth in earnings per share and compelling growth in net income. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Aetna Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

2. As of noon trading, WellPoint ( WLP) is up $0.48 (0.5%) to $91.29 on average volume. Thus far, 953,347 shares of WellPoint exchanged hands as compared to its average daily volume of 2.5 million shares. The stock has ranged in price between $89.26-$91.45 after having opened the day at $89.26 as compared to the previous trading day's close of $90.81.

WellPoint, Inc., a health benefits company, through its subsidiaries, provides a range of medical products in the United States. The company offers a spectrum of network-based managed care health benefit plans to large and small employer, individual, Medicaid, and senior markets. WellPoint has a market cap of $25.3 billion and is part of the health care sector. Shares are down 1.7% year-to-date as of the close of trading on Tuesday. Currently there are 6 analysts who rate WellPoint a buy, no analysts rate it a sell, and 10 rate it a hold.

TheStreet Ratings rates WellPoint as a buy. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, reasonable valuation levels and solid stock price performance. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full WellPoint Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

1. As of noon trading, Express Scripts ( ESRX) is up $0.66 (0.9%) to $76.32 on light volume. Thus far, 1.7 million shares of Express Scripts exchanged hands as compared to its average daily volume of 4.8 million shares. The stock has ranged in price between $74.86-$76.47 after having opened the day at $75.96 as compared to the previous trading day's close of $75.66.

Express Scripts Holding Company provides a range of pharmacy benefit management (PBM) services primarily in the United States and Canada. The company offers healthcare management and administration services on behalf of its clients. Express Scripts has a market cap of $57.8 billion and is part of the health care sector. Shares are up 6.0% year-to-date as of the close of trading on Tuesday. Currently there are 14 analysts who rate Express Scripts a buy, no analysts rate it a sell, and 4 rate it a hold.

TheStreet Ratings rates Express Scripts as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, reasonable valuation levels, good cash flow from operations, growth in earnings per share and largely solid financial position with reasonable debt levels by most measures. We feel these strengths outweigh the fact that the company shows low profit margins. Get the full Express Scripts Ratings Report now.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health services industry could consider ProShares Ultra Short Health Care ( RXD).
null

If you liked this article you might like

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Goldman Bankers (Mostly) Upbeat on Tech M&A and IPO Trends

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

Why a Walgreens Purchase of Humana or WellCare Now Appears Less Likely

5 Awesome Stock Picks That Will Survive a Choppy Market

5 Awesome Stock Picks That Will Survive a Choppy Market

Aetna Is Being Investigated Over Coverage Denials

Aetna Is Being Investigated Over Coverage Denials

Aetna Who? CVS Blows Wall Street Away With Its Earnings